Contrary to our data, other authors showed the ability of pentoxifylline (when tested at higher concentrations than in this work and in a triple-negative breast cancer cell line) to downregulate the Akt and ERK signaling pathways[23]. This evidence concerns the gene AKT1 and triple-negative breast carcinoma.